gms | German Medical Science

14. Jahrestagung der Gesellschaft für Arzneimittelanwendungsforschung und Arzneimittelepidemiologie

Gesellschaft für Arzneimittelforschung und Arzneimittelepidemiologie

15.11. - 16.11.2007, Frankfurt am Main

Comparative evaluation from methods to determinate efficiency potentials in drug utilization

Meeting Abstract

  • corresponding author M. S. Pfannkuche - Universität Bremen, ZeS, AG Arzneimittelanwendungsforschung
  • F. Hoffmann - Universität Bremen, ZeS, AG Arzneimittelanwendungsforschung
  • F. Meyer - AOK Rheinland/Hamburg
  • G. Glaeske - Universität Bremen, ZeS, AG Arzneimittelanwendungsforschung

Gesellschaft für Arzneimittelanwendungsforschung und Arzneimittelepidemiologie e.V. (GAA). 14. Jahrestagung der Gesellschaft für Arzneimittelanwendungsforschung und Arzneimittelepidemiologie. Frankfurt am Main, 15.-16.11.2007. Düsseldorf: German Medical Science GMS Publishing House; 2007. Doc07gaa08

Die elektronische Version dieses Artikels ist vollständig und ist verfügbar unter: http://www.egms.de/de/meetings/gaa2007/07gaa08.shtml

Veröffentlicht: 12. November 2007

© 2007 Pfannkuche et al.
Dieser Artikel ist ein Open Access-Artikel und steht unter den Creative Commons Lizenzbedingungen (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.de). Er darf vervielf&aauml;ltigt, verbreitet und &oauml;ffentlich zug&aauml;nglich gemacht werden, vorausgesetzt dass Autor und Quelle genannt werden.


Gliederung

Text

Context: Discussions in health care policy frequently pursue an raising efficiency in drug utilisation. Therefore saving potentials are quantified based on health insurance companies claims data. However, calculation of saving potentials is a complex matter, because they are depending on different underlying assumptions and abstractions.

Aim of the study: Aim of this study was to present different methods to calculate saving potentials and discuss their advantage and disadvantage.

Material and methods: Claims data from the health insurance company Gmuender ErsatzKasse (GEK) from 2005 were used, to present four different methods to calculate efficiency potentials in the generic drug market. The different effects are illustrated due to Omeprazol.

Results: Depending on the used methods, different estimates, abstractions and varied information are required. In the given example the identified increase in efficiency varies between 741,000 Euro and 165,000 Euro (80%). According to the used method, saving potentials range between 2.9% and 13.1% measured by the total expenditure for Omeprazol.

Conclusion: The amount and the pertinence of saving potentials in theory are highly depending on underlying assumptions and used methods. Calculations on the level of several drugs should in best case occur at the time of prescription under consideration of drug prices. A detailed methods description is required for an appropriate outcome evaluation.